Daniel P Cahill
Overview
Explore the profile of Daniel P Cahill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
197
Citations
15700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamazawa E, Cahill D, Frosch M, Brastianos P, Sullivan R
Acta Neuropathol Commun
. 2025 Mar;
13(1):57.
PMID: 40075463
Background: Collision tumors, involving two distinct neoplasms in a single anatomical site, are rare. Among these, the metastasis of melanoma into an intracranial meningioma is particularly uncommon, with only four...
2.
Lanman T, Youssef G, Huang R, Rahman R, DeSalvo M, Flood T, et al.
Neurooncol Adv
. 2025 Feb;
7(1):vdae227.
PMID: 39911703
Background: Mutant isocitrate dehydrogenase (IDHm) inhibitors represent a novel targeted approach for treating IDHm glioma patients, yet their optimal use in clinical practice outside of clinical trials remains undefined. This...
3.
Riviere-Cazaux C, Keough M, Zuccato J, Kumar R, Schulz S, Warrington A, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39786477
Cerebrospinal fluid (CSF) has emerged as a valuable liquid biopsy source for glioma biomarker discovery and validation. CSF produced within the ventricles circulates through the subarachnoid space, where the composition...
4.
Karschnia P, Young J, Youssef G, Dono A, Hani L, Sciortino T, et al.
Neuro Oncol
. 2024 Nov;
PMID: 39492786
Background: Following surgery, patients with newly diagnosed glioblastoma frequently enter clinical trials. Nuanced risk assessment is warranted to reduce imbalances between study arms. Here, we aimed (I) to analyze the...
5.
Wetzel E, Nohman A, Hsieh A, Reuss D, Unterberg A, Eyupoglu I, et al.
J Neurooncol
. 2024 Oct;
171(2):373-381.
PMID: 39432026
Purpose: Mutations in the Isocitrate Dehydrogenase (IDH) genes, IDH1 or IDH2, define a group of adult diffuse gliomas associated with a younger age at diagnosis and better prognosis than IDH...
6.
Baboli M, Wang F, Dong Z, Dietrich J, Uhlmann E, Batchelor T, et al.
Radiology
. 2024 Sep;
312(3):e232401.
PMID: 39315894
Background: MR spectroscopic imaging (MRSI) can be used to quantify an extended brain metabolic profile but is confounded by changes in tissue water levels due to disease. Purpose: To develop...
7.
Karschnia P, Gerritsen J, Teske N, Cahill D, Jakola A, van den Bent M, et al.
Lancet Oncol
. 2024 Aug;
25(9):e404-e419.
PMID: 39214112
Glioma resection is associated with prolonged survival, but neuro-oncological trials have frequently refrained from quantifying the extent of resection. The Response Assessment in Neuro-Oncology (RANO) resect group is an international,...
8.
Alvarez-Breckenridge C, Brastianos P, Cahill D
Neuro Oncol
. 2024 Aug;
26(11):2100-2101.
PMID: 39207022
No abstract available.
9.
Karschnia P, Tonn J, Cahill D
Clin Cancer Res
. 2024 Aug;
30(21):4811-4812.
PMID: 39163091
Supramaximal resection beyond the contrast-enhancing tumor borders represents an emerging surgical strategy for patients with newly diagnosed glioblastoma. A recent study provides evidence detailing the interactive effects of more aggressive...
10.
Batool S, Escobedo A, Hsia T, Ekanayake E, Khanna S, Gamblin A, et al.
Nat Commun
. 2024 Aug;
15(1):7074.
PMID: 39152110
Glioma represents the most common central nervous system neoplasm in adults. Current classification scheme utilizes molecular alterations, particularly IDH1.R132H, to stratify lesions into distinct prognostic groups. Identification of the single...